Skip to search formSkip to main contentSkip to account menu

LYPD3 gene

Known as: GPI-ANCHORED METASTASIS-ASSOCIATED PROTEIN C4.4A, LYPD3, LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract 3091: Response of C4.4A-positive patient-derived xenograft models of ESCC, HNSCC and bladder cancer to BAY1129980, a C4.4A-targeted antibody drug conjugate
C4.4A (LYPD3) is a cancer- and metastasis-associated transmembrane cell surface protein which is expressed at high frequency and… 
2016
2016
C 4 . 4 A as a biomarker of head and neck squamous cell carcinoma and correlated with epithelial mesenchymal transition
C4.4A, a member of the Ly6/uPAR family of membrane proteins, has been identified as a metastasis-associated molecule, but little… 
2015
2015
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis
BackgroundThe aim of our study was to investigate the association of C4.4A expression in breast tumors with both patients… 
2014
2014
Abstract 5445: Preclinical anti-tumor efficacy of an anti-C4.4a (LYPD3) antibody drug conjugate for the treatment of lung squamous cell carcinoma
C4.4a (LYPD3) has been identified previously as a cancer- and metastasis-associated internalizing cell surface protein. Targeting… 
2013
2013
The metastasis‐associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin
2013
2013
Abstract LB-206: Target validation of C4.4a (LYPD3) as a target for antibody-drug conjugates for the treatment of squamous cell carcinoma of different origin.
C4.4a (LYPD3) is a GPI-anchored cell surface protein with unknown physiological function, although it has been speculated that it… 
2013
2013
C4.4A Expression Is Associated with a Poor Prognosis of Esophageal Squamous Cell Carcinoma
BackgroundC4.4A is a glycolipid-anchored membrane protein expressed in several human malignancies. We examined clinical relevance… 
2011
2011
Establishment of a conditional knock out mouse to investigate the function of C4.4A in liver diseases
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)